These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 15911116

  • 1. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
    Tan YL, Zhou DF, Cao LY, Zou YZ, Zhang XY.
    Neurosci Lett; ; 382(1-2):27-32. PubMed ID: 15911116
    [Abstract] [Full Text] [Related]

  • 2. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S, Gönül AS, Taneli F, Akdeniz F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [Abstract] [Full Text] [Related]

  • 3. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR.
    J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
    [Abstract] [Full Text] [Related]

  • 4. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen DC, Kosten TR, Zhang XY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1508-12. PubMed ID: 19720106
    [Abstract] [Full Text] [Related]

  • 5. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
    Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR.
    J Psychiatr Res; 2007 Nov 13; 41(1-2):31-5. PubMed ID: 16546213
    [Abstract] [Full Text] [Related]

  • 6. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
    Reis HJ, Nicolato R, Barbosa IG, Teixeira do Prado PH, Romano-Silva MA, Teixeira AL.
    Neurosci Lett; 2008 Jul 11; 439(2):157-9. PubMed ID: 18514407
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH, Kim YK.
    Neuropsychobiology; 2009 Jul 11; 59(1):51-8. PubMed ID: 19270464
    [Abstract] [Full Text] [Related]

  • 8. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
    Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F.
    Neurosci Lett; 2007 Jun 08; 420(1):45-8. PubMed ID: 17442489
    [Abstract] [Full Text] [Related]

  • 9. Effects of antipsychotics on the serum BDNF levels in schizophrenia.
    Chen CC, Huang TL.
    Psychiatry Res; 2011 Oct 30; 189(3):327-30. PubMed ID: 21320726
    [Abstract] [Full Text] [Related]

  • 10. The interplay between BDNF and oxidative stress in chronic schizophrenia.
    Zhang XY, Chen DC, Tan YL, Tan SP, Wang ZR, Yang FD, Okusaga OO, Zunta-Soares GB, Soares JC.
    Psychoneuroendocrinology; 2015 Jan 30; 51():201-8. PubMed ID: 25462893
    [Abstract] [Full Text] [Related]

  • 11. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
    Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F.
    Bipolar Disord; 2009 Sep 30; 11(6):663-71. PubMed ID: 19689509
    [Abstract] [Full Text] [Related]

  • 12. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia.
    Rizos EN, Michalopoulou PG, Siafakas N, Stefanis N, Douzenis A, Rontos I, Laskos E, Kastania A, Zoumpourlis V, Lykouras L.
    Neuropsychobiology; 2010 Sep 30; 62(2):87-90. PubMed ID: 20523079
    [Abstract] [Full Text] [Related]

  • 13. Investigation of serum BDNF levels in drug-naive patients with schizophrenia.
    Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulou PG, Vasilopoulos D, Gournellis R, Lykouras L.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul 01; 32(5):1308-11. PubMed ID: 18502013
    [Abstract] [Full Text] [Related]

  • 14. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
    Qi LY, Xiu MH, Chen DC, Wang F, Kosten TA, Kosten TR, Zhang XY.
    Neurosci Lett; 2009 Sep 22; 462(2):113-7. PubMed ID: 19539717
    [Abstract] [Full Text] [Related]

  • 15. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G, Di Iorio G, Marini S, Ricci V, De Berardis D, Di Giannantonio M.
    J Biol Regul Homeost Agents; 2012 Sep 22; 26(3):347-56. PubMed ID: 23034254
    [Abstract] [Full Text] [Related]

  • 16. Testosterone in first-episode schizophrenia.
    Cesková E, Prikryl R, Kaspárek T.
    Neuro Endocrinol Lett; 2007 Dec 22; 28(6):811-4. PubMed ID: 18063925
    [Abstract] [Full Text] [Related]

  • 17. Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.
    Huang TL, Lee CT.
    J Psychiatr Res; 2006 Oct 22; 40(7):664-8. PubMed ID: 16386272
    [Abstract] [Full Text] [Related]

  • 18. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
    Pedrini M, Chendo I, Grande I, Lobato MI, Belmonte-de-Abreu PS, Lersch C, Walz J, Kauer-Sant'anna M, Kapczinski F, Gama CS.
    Neurosci Lett; 2011 Mar 24; 491(3):207-10. PubMed ID: 21256922
    [Abstract] [Full Text] [Related]

  • 19. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery.
    Nakazato M, Hashimoto K, Yoshimura K, Hashimoto T, Shimizu E, Iyo M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1117-21. PubMed ID: 16753247
    [Abstract] [Full Text] [Related]

  • 20. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, Nakano Y, Shinkai K, Mitoma M, Ohta M, Shinkai T, Nakamura J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1072-7. PubMed ID: 17459549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.